Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesDose-Modified Oral Chemotherapy in the Treatment of AIDS-Related Non-Hodgkins Lymphoma in East Africa
Journal of Clinical Oncology, 05/28/09
Mwanda WO et al. - Dose-modified oral chemotherapy is efficacious, has comparable outcome to that in the United States in the pre–highly active antiretroviral therapy setting, has an acceptable safety profile, and is pragmatic in sub-Saharan Africa. The international collaboration has been highly successful, and subsequent projects should focus on strategies to optimize combination antiretroviral therapy and chemotherapy and follow-up tissue correlative studies.
Related Articles
Primary Extranodal Non-Hodgkin Lymphoma of the Gingiva Initially Misdiagnosed as Dental Abscess
Quintessence International, 11/23/09
Relevance Score: 67%
Hepatocellular carcinoma infiltrated with non-Hodgkins lymphoma: Report of a case
Surgery Today, 11/11/09
Relevance Score: 67%
Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkins lymphoma: The Iowa Womens Health Study
International Journal of Cancer, 11/05/09
Relevance Score: 67%
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma
Leukemia and Lymphoma, 11/04/09
Relevance Score: 66%
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas - the PETAL trial
Leukemia and Lymphoma, 11/04/09
Relevance Score: 66%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor